Page 5 - Buzz Show News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Auris Medical Provides Update on Bentrio Program in Allergy” Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, and its affiliate Altamira Medica Ltd. today announced additional details on the outcomes from the clinical investigation of its BentrioTM nasal spray in allergic rhinitis and provided an update on the regulatory pathway in the US for the intend...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “MicroVision Announces Completion of its Long-Range Lidar Sensor A-Sample Hardware and Development Platform” MicroVision, Inc. (NASDAQ: MVIS) gained over 10% in premarket trading after announcing the Completion of its Long-Range Lidar Sensor A-Sample Hardware and Development Platform. The Company has completed development of its platform for demonstration of key performance features of its long-range lidar sensor to potential customers, partners, or parties interested in strategic alternatives. MicroVision ...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ADMA Biologics Receives FDA Approval for Increased Intravenous Immune Globulin Production Scale” ADMA Biologics (NASDAQ: ADMA), Inc. shot up over 23% in premarket trading after the company was granted approval for an Increased Intravenous Immune Globulin Production Scale by the FDA. The 4,400-liter IVIG plasma pool scale for BIVIGAM® will allow ADMA to expand its manufacturing plant’s total processing capacity from 400,000 liters to an anticipated peak throughput of up to 600,000 liters. ADMA Biologics ...

Sponsored Content Release FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our...

FinancialBuzz.com’s latest Affimed N.V. (NASDAQ: AFMD) surged over 30% in premarket trading after the company announced positive initial clinical data from an investigator-sponsored study at The University of Texas MD Anderson Cancer Center. The study evaluated cord blood-derived natural killer cells pre-complexed with Affimed’s innate cell engager and all four patients experienced significant disease reduction, with two complete responses and two partial responses as assessed by the investigator, with an objective response rate of 100%. Affimed is a clinical-stage immuno-oncology compa...